Ex-Pfizer CEO Ian Read sees 2018 pay slashed by a third as incentive package plummets
In 2017, Pfizer’s board of directors was throwing money at CEO Ian Read to persuade him to stay at least through March of this year. His total compensation jumped more than 60% to $ 27.9 million, though a lot of that came from equity-based incentives. Read is staying, but not in the role on which… Read More »